Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 53, 2018 - Issue 5
Submit an article Journal homepage
209
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study

Antonella GalloInstitute of Internal Medicine, Catholic University, Rome, ItalyCorrespondence[email protected]
,
Carla ValloneInstitute of Internal Medicine, Catholic University, Rome, Italy
,
Ludovico SabatelliInstitute of Internal Medicine, Catholic University, Rome, Italy
,
Giulio VenturaInstitute of Internal Medicine, Catholic University, Rome, Italy
,
Marcello CovinoInstitute of Internal Medicine, Catholic University, Rome, Italy
,
Giovanni CammarotaInstitute of Internal Medicine, Catholic University, Rome, Italy
,
Antonio GasbarriniInstitute of Internal Medicine, Catholic University, Rome, Italy
,
Raffaele LandolfiInstitute of Internal Medicine, Catholic University, Rome, Italy
&
Massimo MontaltoInstitute of Internal Medicine, Catholic University, Rome, Italy
 show all
Pages 567-572 | Received 07 Aug 2017, Accepted 09 Oct 2017, Published online: 24 Oct 2017

References

  • Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013;173:1359–1367.
  • Lofgren ET, Cole SR, Weber DJ, et al. Hospital-acquired Clostridium difficile infections: estimating all-cause mortality and length of stay. Epidemiology. 2014;25:570–575.
  • Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008;359:1932–1940.
  • Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377:63–73.
  • Miller MA, Louie T, Mullane K, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis. 2013;13:148.
  • Belmares J, Gerding DN, Parada JP, et al. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect. 2007;55:495–501.
  • Fujitani S, George WL, Murthy AR. Comparison of clinical severity score indices for Clostridium difficile Infection. Infect Control Hosp Epidemiol. 2011;32:220–228.
  • Kelly CP, Kyne L. The host immune response to Clostridium difficile. J Med Microbiol. 2011;60:1070–1079.
  • Steiner TS, Flores CA, Pizarro TT, et al. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol. 1997;4:719–722.
  • von Roon AC, Karamountzos L, Purkayastha S, et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007;102:803–813.
  • Montalto M, Curigliano V, Santoro L, et al. Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. Am J Gastroenterol. 2007;102:132–136.
  • Montalto M, Gallo A, Santoro L, et al. Role of fecal calprotectin in gastrointestinal disorders. Eur Rev Med Pharmacol Sci. 2013;17:1569–1582.
  • Kopylov U, Rosenfeld G, Bressler B, et al. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:742–756.
  • Shastri YM, Bergis D, Povse N, et al. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea. Am J Med. 2008;121:1099–1106.
  • Whitehead SJ, Shipman KE, Cooper M, et al. Is there any value in measuring faecal calprotectin in Clostridium difficile positive faecal samples? J Med Microbiol. 2014;63:590–593.
  • Swale A, Miyajima F, Roberts P, et al. Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study. PLoS One. 2014;9:e106118.
  • Rao K, Santhosh K, Mogle JA, et al. Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults. Infect Dis. 2016;48:663–669.
  • Kim J, Kim H, Oh HJ, et al. Fecal calprotectin level reflects the severity of Clostridium difficile Infection. Ann Lab Med. 2017;37:53–57.
  • Peretz A, Tkhawkho L, Pastukh N, et al. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection. BMC Infect Dis. 2016;16:309.
  • Montalto M, Curigliano V, Santoro L, et al. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. Eur J Gastroenterol Hepatol. 2006;18:965–967.
  • Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22–32.
  • Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313:398–408.
  • Stevens VW, Nelson RE, Schwab-Daugherty EM, et al. Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection. JAMA Intern Med. 2017;177:546–553.
  • Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. Cochrane Database Syst Rev. 2017;3:CD004610.
  • O’Horo JC, Jindai K, Kunzer B, et al. Treatment of recurrent Clostridium difficile infection: a systematic review. Infection 2014;42:43–59.
  • Johnson S, Gerding DN. Fidaxomicin ‘chaser’ regimen following vancomycin for patients with multiple Clostridium difficile recurrences. Clin Infect Dis. 2013;56:309–310.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.